Affitech AS Appoints New Board Member

OSLO, Norway--(BUSINESS WIRE)--The human antibody company, Affitech AS, announced today the appointment of Dr. Thomas von Rüden, currently the Chief Executive Officer of Cologne, Germany-based Direvo Biotech AG as a Member of its Supervisory Board.
MORE ON THIS TOPIC